Commercially focussed Chartered & European Patent Attorneys providing intellectual property (IP) services to innovative companies worldwide. Our experienced IP professionals deliver exceptional service and tangible results.
Secerna is a firm of commercially focussed Chartered & European Patent Attorneys. The team operates globally, representing and protecting the interests of multi-national corporations, FTSE and NYSE listed companies, universities, spin-out companies, small businesses and innovators worldwide.
We help our clients create and extract the maximum value from their intellectual property while minimizing costs, advising on the best IP strategies to meet their commercial goals. Our services include:
We represent our clients directly at the UK Intellectual Property Office, European Patent Office, and World International Property Organization in all aspects of intellectual property matters.
We build long-term business relationships with our clients, based on exceptional trust, teamwork and value for money.
We work hand in hand with you to find the best strategies to meet your business goals.
Our team combines considerable technical know-how and sector expertise with extensive commercial acumen.
This series continues to explore the fascinating world of pharmaceuticals. Next up is QUVIVIQ® (from Idorsia Pharamceuticals) is a medicine for treating adults with insomnia (difficulty falling asleep or staying asleep).
Read moreSuccess can be a double-edged sword. Reputation is what all brands strive for, but this can come at a price, and brand owners need to take steps to appropriately ringfence this reputation. If a brand owner does not take the appropriate steps, including protecting and enforcing their trade mark rights, there is a risk of those marks becoming unprotectable generic terms (also known as genericide), subsequently losing their trade mark significance.
Read moreThis series continues to explore the fascinating world of pharmaceuticals. Next up is PAXLOVID® an oral antiviral medication developed by Pfizer to treat mild-to-moderate COVID-19 in adults who are at high risk of progressing to severe illness.
Read moreAre you a Part-Qualified Patent Attorney looking to take your career to the next level? Secerna LLP is excited to announce an exceptional opportunity to join our dynamic Physics and Engineering team. We're seeking a talented and ambitious individual to build upon their existing patent experience in a supportive and collaborative environment, working at the forefront of technological innovation.
Read moreA year of economic uncertainty appears to have given way to renewed confidence in the world of intellectual property, according to figures released today by the World Intellectual Property Organization (WIPO). After a dip in 2023, the organisation’s key registries have seen a marked uptick in patent, trade mark, and design applications, suggesting that global innovation is once again on the rise.
Read moreThis series continues to explore the fascinating world of pharmaceuticals. Next up is MAVIRET® (from AbbVie), also sold under the brand name MAVYRET®, uses a combination of glecaprevir and pibrentasvir for the treatment of chronic hepatitis C infection.
Read more
